Evidence map›Paper›PMID 37658125›Full record

ArticleScientific reports2023

Cost-effective, portable, patient-dedicated three-dimensional automated breast ultrasound for point-of-care breast cancer screening.

Claire Keun Sun Park, Tiana Trumpour, Amal Aziz, Jeffrey Scott Bax, David Tessier, Lori Gardi, Aaron Fenster

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Wearable bioelectronics for cancer theranostics.Microsystems & nanoengineering · 2025
    Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Claire Keun Sun ParkDepartment of Medical Biophysics, Schulich School of Medicine and Dentistry, Western University, London, ON, N6A 3K7, Canada. cpark223@uwo.ca.
Tiana TrumpourDepartment of Medical Biophysics, Schulich School of Medicine and Dentistry, Western University, London, ON, N6A 3K7, Canada.
Amal AzizRobarts Research Institute, 1151 Richmond St. N., London, ON, N6A 5B7, Canada.
Jeffrey Scott BaxRobarts Research Institute, 1151 Richmond St. N., London, ON, N6A 5B7, Canada.
David TessierRobarts Research Institute, 1151 Richmond St. N., London, ON, N6A 5B7, Canada.
Lori GardiRobarts Research Institute, 1151 Richmond St. N., London, ON, N6A 5B7, Canada.
Aaron FensterDepartment of Medical Biophysics, Schulich School of Medicine and Dentistry, Western University, London, ON, N6A 3K7, Canada.
Robarts Clinical Trials · CAWestern University · CA

Funding

CIHR
6 · The paper itself

Abstract

Breast cancer screening has substantially reduced mortality across screening populations. However, a clinical need persists for more accessible, cost-effective, and robust approaches for increased-risk and diverse patient populations, especially those with dense breasts where screening mammography is suboptimal. We developed and validated a cost-effective, portable, patient-dedicated three-dimensional (3D) automated breast ultrasound (ABUS) system for point-of-care breast cancer screening. The 3D ABUS system contains a wearable, rapid-prototype 3D-printed dam assembly, a compression assembly, and a computer-driven 3DUS scanner, adaptable to any commercially available US machine and transducer. Acquisition is operator-agnostic, involves a 40-second scan time, and provides multiplanar 3D visualization for whole-breast assessment. Geometric reconstruction accuracy was evaluated with a 3D grid phantom and tissue-mimicking breast phantoms, demonstrating linear measurement and volumetric reconstruction errors < 0.2 mm and < 3%, respectively. The system's capability was demonstrated in a healthy male volunteer and two healthy female volunteers, representing diverse patient geometries and breast sizes. The system enables comfortable ultrasonic coupling and tissue stabilization, with adjustable compression to improve image quality while alleviating discomfort. Moreover, the system effectively mitigates breathing and motion, since its assembly affixes directly onto the patient. While future studies are still required to evaluate the impact on current clinical practices and workflow, the 3D ABUS system shows potential for adoption as an alternative, cost-effective, dedicated point-of-care breast cancer screening approach for increased-risk populations and limited-resource settings.

Indexed as

Breast NeoplasmsEarly Detection of CancerCost-Benefit AnalysisFemaleHumansMaleMammographyPoint-of-Care Systems

Identifiers

PMID37658125
PMCPMC10474273
OpenAlexW4386378172

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.